Continuous Versus Bolus Infusion of Doxorubicin in Children With ALL: Long-term Cardiac Outcomes

BACKGROUND AND OBJECTIVES: Doxorubicin, effective against many malignancies, is limited by cardiotoxicity. Continuous-infusion doxorubicin, compared with bolus-infusion, reduces early cardiotoxicity in adults. Its effectiveness in reducing late cardiotoxicity in children remains uncertain. We determ...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Lipshultz, Steven E., Miller, Tracie L., Lipsitz, Stuart R., Neuberg, Donna S., Dahlberg, Suzanne E., Colan, Steven D., Silverman, Lewis B., Henkel, Jacqueline M., Franco, Vivian I., Cushman, Laura L., Asselin, Barbara L., Clavell, Luis A., Athale, Uma, Michon, Bruno, Laverdière, Caroline, Schorin, Marshall A., Larsen, Eric, Usmani, Naheed, Sallan, Stephen E.
Formato: Artigo
Idioma:Inglês
Publicado em: American Academy of Pediatrics 2012
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3507254/
https://ncbi.nlm.nih.gov/pubmed/23166343
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1542/peds.2012-0727
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados